Recombinant human alpha 1-antitrypsin | |
---|---|
Trade Name | |
Orphan Indication | Bronchopulmonary dysplasia |
USA Market Approval | USA |
USA Designation Date | 2005-04-28 00:00:00 |
Sponsor | Arriva Pharmaceuticals, Inc.;1010 Atlantic Avenue;Alameda, California, 94501 |